{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,17]],"date-time":"2026-02-17T15:31:41Z","timestamp":1771342301573,"version":"3.50.1"},"reference-count":24,"publisher":"Frontiers Media SA","content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Neurol."],"DOI":"10.3389\/fneur.2016.00027","type":"journal-article","created":{"date-parts":[[2016,3,8]],"date-time":"2016-03-08T10:52:42Z","timestamp":1457434362000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":19,"title":["Espresso Coffee for the Treatment of Somnolence in Parkinson\u2019s Disease: Results of n-of-1 Trials"],"prefix":"10.3389","volume":"7","author":[{"given":"Joaquim J.","family":"Ferreira","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tiago","family":"Mestre","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leonor Correia","family":"Guedes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miguel","family":"Coelho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M\u00e1rio M.","family":"Rosa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ana T.","family":"Santos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M\u00e1rcio","family":"Barra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cristina","family":"Sampaio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Olivier","family":"Rascol","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2016,3,8]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1001\/jama.287.4.455","article-title":"Excessive daytime sleepiness and sudden-onset sleep in Parkinson disease: a survey by the Canadian Movement Disorders Group","volume":"287","author":"Hobson","year":"2002","journal-title":"JAMA"},{"key":"B2","first-page":"217","article-title":"Early (uncomplicated) Parkinson\u2019s disease","volume-title":"European Handbook of Neurological Management","author":"Oertel","year":"2011"},{"issue":"Suppl 3","key":"B3","doi-asserted-by":"publisher","first-page":"S42","DOI":"10.1002\/mds.23884","article-title":"The movement disorder society evidence-based medicine review update: treatments for the non-motor symptoms of Parkinson\u2019s disease","volume":"26","author":"Seppi","year":"2011","journal-title":"Mov Disord"},{"key":"B4","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1007\/s004150170148","article-title":"Successful treatment of excessive daytime sleepiness in Parkinson\u2019s disease with modafinil","volume":"248","author":"Happe","year":"2001","journal-title":"J Neurol"},{"key":"B5","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1016\/S1353-8020(00)00035-3","article-title":"Modafinil for the treatment of excessive daytime sleepiness in Parkinson\u2019s disease: a case report","volume":"7","author":"Rabinstein","year":"2001","journal-title":"Parkinsonism Relat Disord"},{"key":"B6","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1093\/sleep\/25.8.62","article-title":"Modafinil for the treatment of daytime sleepiness in Parkinson\u2019s disease: a double-blind, randomized, crossover, placebo-controlled polygraphic trial","volume":"25","author":"Hogl","year":"2002","journal-title":"Sleep"},{"key":"B7","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1097\/00002826-200203000-00010","article-title":"Treatment of excessive daytime sleepiness in patients with Parkinson\u2019s disease with modafinil","volume":"25","author":"Nieves","year":"2002","journal-title":"Clin Neuropharmacol"},{"key":"B8","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1002\/mds.10390","article-title":"Randomized trial of modafinil for treating subjective daytime sleepiness in patients with Parkinson\u2019s disease","volume":"18","author":"Adler","year":"2003","journal-title":"Mov Disord"},{"key":"B9","doi-asserted-by":"publisher","first-page":"1636","DOI":"10.1136\/jnnp.2005.065870","article-title":"Modafinil for daytime somnolence in Parkinson\u2019s disease: double blind, placebo controlled parallel trial","volume":"76","author":"Ondo","year":"2005","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"B10","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1212\/WNL.0b013e318263570d","article-title":"Caffeine for treatment of Parkinson disease: a randomized controlled trial","volume":"79","author":"Postuma","year":"2012","journal-title":"Neurology"},{"key":"B11","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1136\/jnnp.55.3.181","article-title":"Accuracy of clinical diagnosis of idiopathic Parkinson\u2019s disease: a clinico-pathological study of 100 cases","volume":"55","author":"Hughes","year":"1992","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"B12","doi-asserted-by":"publisher","first-page":"293","DOI":"10.7326\/0003-4819-112-4-293","article-title":"The n-of-1 randomized controlled trial: clinical usefulness. Our three-year experience","volume":"112","author":"Guyatt","year":"1990","journal-title":"Ann Intern Med"},{"key":"B13","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1093\/sleep\/14.6.540","article-title":"A new method for measuring daytime sleepiness: the Epworth sleepiness scale","volume":"14","author":"Johns","year":"1991","journal-title":"Sleep"},{"key":"B14","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1136\/bmj.309.6961.1041","article-title":"n of 1 trials comparing a non-steroidal anti-inflammatory drug with paracetamol in osteoarthritis","volume":"309","author":"March","year":"1994","journal-title":"BMJ"},{"key":"B15","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1111\/j.1526-4610.2004.04199.x","article-title":"Dextroamphetamine pilot crossover trials and n of 1 trials in patients with chronic tension-type and migraine headache","volume":"44","author":"Haas","year":"2004","journal-title":"Headache"},{"key":"B16","doi-asserted-by":"publisher","first-page":"1292","DOI":"10.1001\/archpedi.153.12.1292","article-title":"Double-blind methylphenidate trials: practical, useful, and highly endorsed by families","volume":"153","author":"Kent","year":"1999","journal-title":"Arch Pediatr Adolesc Med"},{"key":"B17","doi-asserted-by":"crossref","first-page":"100","DOI":"10.5694\/j.1326-5377.2000.tb139254.x","article-title":"Preliminary experiences with a single-patient trials service in general practice","volume":"173","author":"Nikles","year":"2000","journal-title":"Med J Aust"},{"key":"B18","doi-asserted-by":"publisher","first-page":"2427","DOI":"10.1002\/mds.23873","article-title":"Caffeine in Parkinson\u2019s disease: a pilot open-label, dose-escalation study","volume":"26","author":"Altman","year":"2011","journal-title":"Mov Disord"},{"key":"B19","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1111\/j.1472-8206.2011.00951.x","article-title":"A proof-of-concept, randomized, placebo-controlled, multiple cross-overs (n-of-1) study of naftazone in Parkinson\u2019s disease","volume":"26","author":"Rascol","year":"2012","journal-title":"Fundam Clin Pharmacol"},{"key":"B20","doi-asserted-by":"publisher","first-page":"992","DOI":"10.1136\/jnnp.2004.043273","article-title":"Tourette\u2019s syndrome and deep brain stimulation","volume":"76","author":"Houeto","year":"2005","journal-title":"J Neuro Neurosurg Psychiatry"},{"key":"B21","doi-asserted-by":"publisher","first-page":"22","DOI":"10.3109\/00365528809099154","article-title":"An N of 1 service: applying the scientific method in clinical practice","volume":"147","author":"Keller","year":"1988","journal-title":"Scand J Gastroenterol Suppl"},{"key":"B22","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1186\/1471-2296-7-54","article-title":"Conducting research in individual patients: lessons learnt from two series of N-of-1 trials","volume":"7","author":"Wegman","year":"2006","journal-title":"BMC Fam Pract"},{"key":"B23","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1378\/chest.115.1.38","article-title":"Theophylline for irreversible chronic airflow limitation: a randomized study comparing n of 1 trials to standard practice","volume":"115","author":"Mahon","year":"1999","journal-title":"Chest"},{"key":"B24","first-page":"140","article-title":"The efficacy and cost effectiveness of N of 1 studies with diclofenac compared to standard treatment with nonsteroidal antiinflammatory drugs in osteoarthritis","volume":"31","author":"Pope","year":"2004","journal-title":"J Rheumatol"}],"container-title":["Frontiers in Neurology"],"original-title":[],"deposited":{"date-parts":[[2020,9,16]],"date-time":"2020-09-16T20:59:16Z","timestamp":1600289956000},"score":1,"resource":{"primary":{"URL":"http:\/\/journal.frontiersin.org\/Article\/10.3389\/fneur.2016.00027\/abstract"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,3,8]]},"references-count":24,"URL":"https:\/\/doi.org\/10.3389\/fneur.2016.00027","relation":{},"ISSN":["1664-2295"],"issn-type":[{"value":"1664-2295","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,3,8]]}}}